Searched for
SANDOZ
Insider trading: Supreme Court upholds SAT clearance to Biocon MDThe Supreme Court has backed a tribunal's decision, clearing Biocon's managing director, Shreehas P Tambe, of insider trading allegations f...- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Dr Reddy’s shares fall 2% after Goldman Sachs downgrades, Citi turns cautiousDr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa businessStrides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...
- Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...
- Novartis to spin off generics biz sandozThe company started a strategic review of Sandoz last October - examining a range of options, including retaining the business, spinning it...
- Swiss drugmaker Novartis to spin off generics unit SandozThe Basel-based company, which makes a vast array of drugs including cancer treatment Gleevec and Diovan for hypertension, says it wants to...
- Aurobindo Pharma aims to become debt free in 3 years sans Sandoz dealIn September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations ...
- Aurobindo’s buyout of Sandoz assets delayed on FTC queryOn Wednesday, shares of Aurobindo closed 4.8 per cent lower at Rs 450.75 on the BSE.
- Aurobindo buys US units of Sandoz for $900 millionThe acquired business has been carved out by the management of Sandoz for divestment.
- Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash dealThe acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities ...
- Biocon teams up with Swiss drugmaker Sandoz for next gen biosimilarUnder the terms of the agreement, both companies will share responsibility for end to end development, manufacturing and global regulatory ...
- Biocon teams up with Sandoz for next-gen BiosimilarsBiosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.
- Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
- Sandoz gets US FDA warning letter for Turbhe, Kalwe sitesThe observations in the warning letter dated October 22 are related to deficiencies in current good manufacturing practice (cGMP) for finis...
- Sandoz gets warning letter for Turbhe, Kalwe siteSandoz, the generic drug arm of Swiss giant Novartis, has received a warning letter from the US FDA on October 22 for its two Indian sites ...
- Cipla gains as partner Sandoz gets USFDA approval for generic drugCipla surged over 4% in trade after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules.
- Sandoz Inc recalls India-made anti-allergic tablets in USDrug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity con...
Load More
